J. J. van Doormaal - Concepedia

Author

J. J. van Doormaal

Also Known As

J J van Doormaal, J. J. Doormaal, J. J. VAN DOORMAAL, J. J. Van Doormaal, J. J. v. Doormaal, J. J. van Doormaal, J.J van Doormaal, J.J. VAN DOORMAAL, J.J. Van Doormaal, J.J. van Doormaal

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Groningen University Medical Center Groningen Gdańsk Medical University Dialyse Centrum Groningen

About

J. J. van Doormaal is an author at University of Groningen specializing in medicine, health sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	587
2	Health Sciences	7	7	322
3	Allergy	2	2	101
4	Cell Biology	1	1	26
5	Clinical Nutrition	1	1	42

J. J. van Doormaal

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis Joanne N.G. Oude Elberink, Jan G.R. de Monchy, J. W. KORS, Journal of Allergy and Clinical Immunology	1997	201
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis Peter Valent, Luís Escribano, Sigurd Broesby‐Olsen, Allergy European Competence NetworkMast Cell DisorderSuspected MastocytosisDiagnosisPathology	2014	170
Imatinib mesylate in the treatment of systemic mastocytosis Helga Droogendijk, Hanneke C. Kluin‐Nelemans, J. J. van Doormaal, Cancer	2006	146
High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis E. van der Veer, W. van der Goot, Jan G.R. de Monchy, Allergy	2012	130
Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis J. W. KORS, J. J. van Doormaal, Jan G.R. de Monchy Journal of Internal Medicine Autoimmune DiseaseAllergyMast Cell DisorderSystemic MastocytosisImmunology	1993	82
Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Huib A.M. Kerstjens, D.S. Postma, J. J. van Doormaal, Thorax	1994	77
Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol S. C. Riemens, Ad H. Oostdijk, J. J. van Doormaal, Osteoporosis International Bone DiseaseTransplantation SurgeryBone LossBone HealthHepatology	1996	69
Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil Eugène van Puijenbroek, Peggy W G du Buf-Vereijken, P. F. M. J. Spooren, Journal of Internal Medicine	1996	66
Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions J. J. van Doormaal, E. van der Veer, Pieter C. van Voorst Vader, Allergy	2012	64
Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein Paul L. van Haelst, J. J. van Doormaal, Johan F. May, European Journal of Internal Medicine InflammationC-reactive ProteinMedicineCell AdhesionSecondary Prevention	2001	63

Page 1